Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours.
Jamieson D, Griffin MJ, Sludden J, Drew Y, Cresti N, Swales K, Merriman M, Allen R, Bevan P, Buerkle M, Mala C, Coyle V, Rodgers L, Dean E, Greystoke A, Banerji U, Wilson RH, Evans TR, Anthoney A, Ranson M, Boddy AV, Plummer R. Jamieson D, et al. Among authors: evans tr. Eur J Cancer. 2016 Nov;68:1-10. doi: 10.1016/j.ejca.2016.08.026. Epub 2016 Sep 28. Eur J Cancer. 2016. PMID: 27693888 Free article. Clinical Trial.
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases.
Plummer R, Greystoke A, Naylor G, Sarker D, Anam ANMK, Prenen H, Teuwen LA, Van Cutsem E, Dekervel J, Haugk B, Ness T, Bhoi S, Jensen M, Morris T, Baumann P, Sjögren N, Tunblad K, Wallberg H, Öberg F, Evans TRJ. Plummer R, et al. Among authors: evans trj. J Hepatocell Carcinoma. 2024 Oct 24;11:2033-2047. doi: 10.2147/JHC.S481410. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39469286 Free PMC article. Clinical Trial.
The potential of preregistration in psychology: Assessing preregistration producibility and preregistration-study consistency.
van den Akker OR, Bakker M, van Assen MALM, Pennington CR, Verweij L, Elsherif MM, Claesen A, Gaillard SDM, Yeung SK, Frankenberger JL, Krautter K, Cockcroft JP, Kreuer KS, Evans TR, Heppel FM, Schoch SF, Korbmacher M, Yamada Y, Albayrak-Aydemir N, Alzahawi S, Sarafoglou A, Sitnikov MM, Děchtěrenko F, Wingen S, Grinschgl S, Hartmann H, Stewart SLK, de Oliveira CMF, Ashcroft-Jones S, Baker BJ, Wicherts JM. van den Akker OR, et al. Among authors: evans tr. Psychol Methods. 2024 Oct 10. doi: 10.1037/met0000687. Online ahead of print. Psychol Methods. 2024. PMID: 39388105
UK Reproducibility Network open and transparent research practices survey dataset.
Hughes-Noehrer L, Aubert Bonn N, De Maria M, Evans TR, Farran EK, Fortunato L, Henderson EL, Jacobs N, Munafò MR, Stewart SLK, Stewart AJ. Hughes-Noehrer L, et al. Among authors: evans tr. Sci Data. 2024 Aug 23;11(1):912. doi: 10.1038/s41597-024-03786-z. Sci Data. 2024. PMID: 39179613 Free PMC article.
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
Sacco JJ, Jackson R, Corrie P, Danson S, Evans TRJ, Ochsenreither S, Kumar S, Goodman A, Larkin J, Karydis I, Steven N, Lorigan P, Plummer R, Patel P, Psarelli E, Olsson-Brown A, Shaw H, Leyvraz S, Handley L, Rawcliffe C, Nathan P. Sacco JJ, et al. Among authors: evans trj. Eur J Cancer. 2024 May;202:114009. doi: 10.1016/j.ejca.2024.114009. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38547774 Free article. Clinical Trial.
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
Larkin J, Marais R, Porta N, Gonzalez de Castro D, Parsons L, Messiou C, Stamp G, Thompson L, Edmonds K, Sarker S, Banerji J, Lorigan P, Evans TRJ, Corrie P, Marshall E, Middleton MR, Nathan P, Nicholson S, Ottensmeier C, Plummer R, Bliss J, Valpione S, Turajlic S. Larkin J, et al. Among authors: evans trj. Cell Rep Med. 2024 Mar 19;5(3):101435. doi: 10.1016/j.xcrm.2024.101435. Epub 2024 Feb 27. Cell Rep Med. 2024. PMID: 38417447 Free PMC article. Clinical Trial.
247 results